{"id":7441,"date":"2020-03-16T14:44:46","date_gmt":"2020-03-16T13:44:46","guid":{"rendered":"https:\/\/www.endoscopy-campus.com\/?post_type=ec-news&#038;p=7441"},"modified":"2020-03-16T14:44:47","modified_gmt":"2020-03-16T13:44:47","slug":"primary-care-physicians-order-88-of-fit-fecal-dna-tests","status":"publish","type":"ec-news","link":"https:\/\/www.endoscopy-campus.com\/en\/ec-news\/primary-care-physicians-order-88-of-fit-fecal-dna-tests\/","title":{"rendered":"Primary Care Physicians Order 88% of FIT-Fecal DNA Tests"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><em><strong>Douglas K. Rex, MD, FASGE, reviewing Weiser E, et al. J Med Screen 2020 Feb 13.<\/strong><\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This industry-sponsored study examined adherence rates to the fecal immunochemical test (FIT)-fecal DNA test commercially available from Exact Sciences Laboratories. The authors were all associated with the company.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Between September 1, 2016, and August 31, 2017, there were 368,494 Medicare patients (64% female) who had the test ordered, and 71% completed the test. The test was ordered by primary care physicians (PCPs) in 88% of the instances, gastroenterologists in 6%, and other specialists in the remainder. The adherence rate was lower when ordered by PCPs compared to gastroenterologists (71% vs 78%).<\/p>\n\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<figure class=\"wp-block-pullquote\" style=\"border-color:#bd6fb7\"><blockquote><p> COMMENT<br> These results indicate good completion rates for the FIT-fecal DNA test in Medicare beneficiaries, which likely, in part, reflects the company-sponsored navigation program. The strengths of the product continue to be high cancer sensitivity, aggressive marketing and education about colorectal cancer, and the navigation program.<\/p><p>However, the test is less effective and less cost-effective than annual FIT and colonoscopy every 10 years. Colonoscopy remains a very viable average-risk screening option, particularly in this elderly population, for which the false-positive rate of FIT-fecal DNA is high. These data indicate that messaging PCPs in the local practice environment about the value of colonoscopy is the best way to promote the continued high-level use of screening colonoscopy in the U.S.<\/p><\/blockquote><\/figure>\n\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p class=\"wp-block-paragraph\">Note to readers: At the time we reviewed this paper, its publisher noted that it was not in final form and that subsequent changes might be made. <\/p>\n\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-media-text alignwide\" style=\"grid-template-columns:27% auto\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"188\" src=\"https:\/\/www.endoscopy-campus.com\/wp-content\/uploads\/d-rex.jpg\" alt=\"\" class=\"wp-image-5921\"\/><\/figure><div class=\"wp-block-media-text__content\">\n<p class=\"has-large-font-size wp-block-paragraph\">Douglas K. Rex, MD, FASGE <\/p>\n<\/div><\/div>\n\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 class=\"wp-block-heading\">CITATION(S) <\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Weiser E, Parks PD, Swartz RK, et al. Cross-sectional adherence with the multi-target stool DNA test for colorectal cancer screening: real-world data from a large cohort of older adults.\u00a0<em>J Med Screen<\/em>\u00a02020 Feb 13. (Epub ahead of print) (<a rel=\"noreferrer noopener\" href=\"https:\/\/doi.org\/10.1177\/0969141320903756\" target=\"_blank\">https:\/\/doi.org\/10.1177%2F0969141320903756<\/a>)<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Douglas K. Rex, MD, FASGE, reviewing Weiser E, et al. J Med Screen 2020 Feb 13. This industry-sponsored study examined adherence rates to the fecal immunochemical test (FIT)-fecal DNA test commercially available from Exact Sciences Laboratories. The authors were all associated with the company.&nbsp; Between September 1, 2016, and August 31, 2017, there were 368,494 &#8230; <a title=\"Primary Care Physicians Order 88% of FIT-Fecal DNA Tests\" class=\"read-more\" href=\"https:\/\/www.endoscopy-campus.com\/en\/ec-news\/primary-care-physicians-order-88-of-fit-fecal-dna-tests\/\" aria-label=\"Read more about Primary Care Physicians Order 88% of FIT-Fecal DNA Tests\">Read more<\/a><\/p>\n","protected":false},"template":"","categories":[1768,1769],"tags":[1934],"class_list":["post-7441","ec-news","type-ec-news","status-publish","hentry","category-asge-journal-scan","category-asge-kolon","tag-fit-fecal-dna-tests"],"_links":{"self":[{"href":"https:\/\/www.endoscopy-campus.com\/en\/wp-json\/wp\/v2\/ec-news\/7441","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.endoscopy-campus.com\/en\/wp-json\/wp\/v2\/ec-news"}],"about":[{"href":"https:\/\/www.endoscopy-campus.com\/en\/wp-json\/wp\/v2\/types\/ec-news"}],"wp:attachment":[{"href":"https:\/\/www.endoscopy-campus.com\/en\/wp-json\/wp\/v2\/media?parent=7441"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.endoscopy-campus.com\/en\/wp-json\/wp\/v2\/categories?post=7441"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.endoscopy-campus.com\/en\/wp-json\/wp\/v2\/tags?post=7441"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}